Navkar Corporation BUY. Performance Update. CMP Target Price `175 `265. 2QFY2017 Result Update Logistics. Historical share price chart.

Similar documents
Navkar Corporation BUY. Performance Update. CMP Target Price `200 `265. 4QFY2016 Result Update Logistics. Historical share price chart

Amber Enterprises India Ltd

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Hindustan Media Ventures

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Procter & Gamble Hygiene & Health Care

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Navkar Corporation SUBSCRIBE. Capacity Expansion to Augment Revenues; SUBSCRIBE. Issue Open: August 24, 2015 Issue Close: August 26, 2015

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Transport Corporation of India

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Mahindra & Mahindra Ltd.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Century Plyboards Ltd

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Future Supply Chain Solutions Ltd

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,715 Target Price `6,006. 2QFY2017 Result Update Automobile. 3-year price chart

Apollo Micro Systems Ltd

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

MISHRA DHATU NIGAM Ltd.

Avenue Supermarts Limited

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Container Corporation of India

Tata Consultancy Services (TCS)

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Newgen Software Technologies Ltd

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Varroc Engineering Ltd.

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Dr. Reddy s Laboratories

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `390 Target Price - 2QFY2017 Result Update Pharmaceutical. Investment Period -

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,797 Target Price `6,560. 3QFY2017 Result Update Automobile. 3-year price chart

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Cipla REDUCE. Performance Highlights. CMP Target Price `564 `490. 2QFY2017 Result Update Pharmaceutical. Investment Period - 3-Year Daily Price Chart

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Sandhar Technologies Limited

Bajaj Auto ACCUMULATE. Performance Highlights. CMP `2,815 Target Price `3,151. 1QFY2018 Result Update Automobile. 24 July 2017

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

NEUTRAL. Neogen Chemicals Ltd. Issue Open: April 24, 2019 Issue Close: April 26, IPO Note Specialty Chemicals

Simplex Infrastructures

Wipro ACCUMULATE. Performance Highlights CMP. `539 Target Price `582. 1QFY2017 Result Update IT. Investment Period 12 Months

Transcription:

2QFY2017 Result Update Logistics December 2, 2016 Navkar Corporation Performance Update Y/E March (` cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq Net sales 90 86 5.2 90 (0.2) EBITDA 33 37 (9.8) 38 (12.8) EBITDA margin (%) 37.1 43.3 (618bp) 42.4 (536bp) Adjusted PAT 22 22 4.1 24 (4.7) Source: Company, Angel Research Navkar Corporation (NCL) reported a subdued set of numbers for 2QFY2017. The consolidated top-line grew by ~5% yoy; while on the operating front, the company reported a margin contraction on account of prolonged monsoons that resulted in higher operational costs. The net profit grew by ~4% yoy due to lower subdued sales and poor operating performance. Top-line grew ~5% yoy: The consolidated top-line reported lower growth, which is ~5% yoy to ~`90cr mainly on account of change in EXIM mix & few shipping lines discontinuing their incentive structure, resulting in lower tariff. However, volumes at Vapi improved handling 1,225 TEUs in 2QFY17 vs. 305 TEUs in 1QFY17. PAT grew ~4% yoy: On the operating front, the company reported a margin contraction of 618bp yoy to 37.1% on account of prolonged monsoons that resulted in higher operational costs. As a result, the EBITDA de-grew by ~10% yoy to `33cr. However, net profit grew by 4.1% on back of lower interest cost. BUY CMP Target Price Investment Period `175 `265 12 Months Stock Info Sector Market Cap (` cr) Logistics 2,567 Net Debt 161 Beta 0.6 52 Week High / Low 224 / 151 Avg. Daily Volume 13,323 Face Value (Rs) 10 BSE Sensex 26,431 Nifty 8,138 Reuters Code NA Bloomberg Code NACO@IN Shareholding Pattern (%) Promoters 72.9 MF / Banks / Indian Fls 15.1 FII / NRIs / OCBs 7.8 Indian Public / Others 4.3 Outlook and Valuation: We estimate NCL to post a revenue CAGR of ~27% and PAT CAGR of ~31% over FY2016-18E. At the current level, the stock is trading at 15.2x its FY2018E earnings. Historically, NCL has consistently grown at JNPT and increased its utilisation from 68% in FY2012 to 87% in FY2015 by leveraging on its rail advantage during periods when JNPT posted flattish volume growth. Going forward, we expect NCL s utilization to improve and the company to garner a good chunk of business over the next three to four years due to its rail advantage at both JNPT and Vapi. We maintain our Buy recommendation on the stock with a target price of `265. Key Financials Y/E March (` cr) FY2014 FY2015 FY2016 FY2017E FY2018E Net sales 349 329 347 369 561 % chg 4.8 (5.9) 5.6 6.2 52.0 Adj. Net profit 90 68 95 103 164 % chg 58.7 (24.0) 39.0 8.2 59.5 EBITDA margin (%) 35.5 40.7 43.2 42.9 42.3 EPS (`) 6.3 4.8 6.7 7.2 11.5 P/E (x) 27.7 36.5 26.2 24.2 15.2 P/BV (x) 5.8 3.3 1.9 1.8 1.6 RoE (%) 21.0 9.1 7.3 7.3 10.5 RoCE (%) 12.8 9.1 7.5 7.5 10.8 EV/Sales (x) 8.3 9.3 7.7 7.8 5.1 EV/EBITDA (x) 23.5 22.8 17.7 18.1 12.1 Source: Company, Angel Research; Note: CMP as of December 1, 2016 Abs. (%) 3m 1yr 3yr Sensex (6.6) 1.5 27.1 NCL (10.9) (9.3) NA Historical share price chart Source: Company, Angel Research Amarjeet S Maurya 022-40003600 Ext: 6831 amarjeet.maurya@angelbroking.com Please refer to important disclosures at the end of this report 1 240 220 200 180 160 140 120 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16

Exhibit 1: 4QFY2016 Performance Y/E March (` cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq 1HFY17 1HFY16 % chg Net Sales 90 86 5.2 90 (0.2) 177 168 5.4 Staff Costs 8 6 29.3 7 10.6 14 11 24.3 (% of Sales) 8.8 7.1 164 7.9 86 8.1 6.8 123 Other Expenses 49 42 14.8 45 8.9 90 81 10.9 (% of Sales) 54.1 49.6 455 49.6 450 51.1 48.5 253 Total Expenditure 57 49 16.7 52 9.1 104 93 12.5 Operating Profit 33 37 (9.8) 38 (12.8) 72 75 (3.5) OPM 37.1 43.3 (618bp) 42.4 (536bp) 40.9 44.6 Interest 6 12 (50.0) 11 (46.1) 17 25 (33.0) Depreciation 5 5 5.6 5 (0.8) 10 10 0.5 Other Income 3 4 (20.6) 4 (23.4) 12 10 26.8 PBT (excl. Ext Items) 26 24 5.1 26 (2.7) 58 49 16.9 Ext (Income)/Expense - - - - - PBT (incl. Ext Items) 26 24 5.1 26 (2.7) 58 49 16.9 (% of Sales) 28.4 28.4 29.1 32.7 29.5 Provision for Taxation 3 3 3 6 6 9.8 (% of PBT) 12.2 11.4 10.4 11.0 11.7 Reported PAT 22 22 4.1 24 (4.7) 51 44 17.8 PATM 24.9 25.2 26.1 29.1 26.0 Minority Interest After NP Extra-ordinary Items Reported PAT 22 22 4.1 23.5 (4.7) 51 44 17.8 PATM 24.9 25.2 26.1 29.1 26.0 Source: Company, Angel Research December 2, 2016 2

Investment Arguments Upcoming ICD to provide an edge The Vapi region has a huge potential as it is a well developed industrial area. As per the Management and industry sources, the Vapi region accounts for close to 27% of container volumes at JNPT. We believe that the company s inland container depot (ICD; with rail connectivity) at Vapi will enable NCL to garner a good portion of the business from the region. At present, imports headed for the region have to get custom cleared at container freight station (CFS)/ICD at JNPT and are then transported via road. With rail transport being a more economical option compared to road, the imports should head directly to Vapi ICD. As for exports from Vapi region, a large portion (~60%) is stuffed at factory and transported to JNPT. However, the balance 40% or ~170,000 TEUs (less-than-container load [LCL]) which are being transported via road and consolidated at JNPT, can be consolidated at the ICD. Once the scale advantages kick in, and given the rail advantage, the company can also cater to some portion of bulkier factory stuffed cargo. Capacity enhancement at Somathane to aid revenue growth The company has managed to outgrow its peers in the region by attracting volumes on the back of its rail advantage. NCL has been facing capacity constraints at JNPT and is forced to reject certain bulk commodities like PTA, Fiber, Scrap, Marble, etc. Although the current South Gujarat volume of NCL (~70,000 TEUs) is expected to shift to the Vapi ICD, the company will now be able to handle these bulk commodities and effectively utilize its extended capacity. NCL will now also be handling domestic traffic, which it had been rejecting earlier, thus aiding growth. Logistics park at Vapi to be an additional revenue driver The logistics park will be a one-stop solution for importers and exporters, providing a host of warehousing and other value added services. Its close proximity to one of the largest industrial clusters in India augurs well for NCL. Utilizing real estate for debt reduction NCL has approved the opportunistic monetization of 45acres land in Panvel through residential development format. In this, NCL will appoint a developer and inturn will receive a share of ~2 mn sqft of sale area with an expected inflow of `6bn. This will be utilized to reduce debt. December 2, 2016 3

Outlook and Valuation We estimate NCL to post a revenue CAGR of ~27% and PAT CAGR of ~31% over FY2016-18E. At the current level, the stock is trading at 15.2x its FY2018E earnings. Historically, NCL has consistently grown at JNPT and increased its utilisation from 68% in FY2012 to 87% in FY2015 by leveraging on its rail advantage during periods when JNPT posted flattish volume growth. Going forward, we expect NCL s utilization to improve and the company to garner a good chunk of business over the next three to four years due to its rail advantage at both JNPT and Vapi. We maintain our Buy recommendation on the stock with a target price of `265. Downside risks to our estimates include The company is exposed to currency risk with foreign currency debt of `194cr on its balance sheet (as of 31-03-2015). The company uses dollar call options to hedge against dollar appreciation and as per the term, the foreign currency debt will get converted to INR debt upon dollar rate hitting the strike price. In this event, the interest rate on the INR debt will be at ~12%. Currently the company is paying lower taxes, with it getting tax benefits for its CFS operations. Once the exemption period is over, the company will have to pay higher taxes, which could impact its earnings growth. Delay in capacity expansion and lower than expected utilization of existing CFS as well as existing players increasing their capacity at JNPT could impact the profitability of the company. Delay in capacity enhancement at JNPT can also impact the top-line. The company operates a private freight terminal (PFT) at JNPT which has helped the company in increasing its volumes. Lapse in agreement with the Indian Railways will lead to the company being unable to operate its PFT. December 2, 2016 4

Company Background NCL is a CFS operator with three CFSs, Ajivali CFS I and Ajivali CFS II at Ajivali and one at Somathane. All of its CFS units are strategically located in close proximity to JNPT which is the largest container port in India. As of May 31, 2015, NCL s CFSs had an aggregate installed handling capacity of 310,000 TEUs per annum. It has a PFT which facilitates loading and unloading of cargo from container trains operating between Somathane CFS and JNPT and to transport domestic cargo to and from inland destinations on the Indian rail network. As of May 31, 2015, it also owns and operates 516 trailers for the transportation of cargo between its CFSs and the JN Port by road. The company offers services like cargo storage facilities at CFSs, packing, labeling/bar-coding, palletizing, fumigation and other related activities. It also provides warehousing facilities, for which, it occupies an aggregate area of 500,000 sq ft. Exhibit 2: CFS details Particulars Ajivali CFS I Ajivali CFS II Somathane CFS Somathane/Ashte Location Ajivali village, Panvel Ajivali village, Panvel village, Panvel Area Custom Notified 135,156 sq. ft. 428,400 sq. ft. 1,073,224.35 sq. ft. Operational since May 12, 2008 May 18, 2006 May 11, 2009 Installed Capacity per annum 25,000 TEUs 65,000 TEUs 220,000 TEUs Bonded warehouse - 27,641 sq. feet 33,141 sq. feet Reefer Points 16 24 52 Temperature controlled chambers - 500 m - Authorized to handle, Authorized to handle, store and deliver store and deliver Hazardous cargo - hazardous cargo up to hazardous cargo, up the total installed capacity per annum to the total installed capacity per annum Connectivity Road Road Rail and road Source: Company, Angel Research December 2, 2016 5

Consolidated Profit & Loss Statement Y/E March (` cr) FY2014 FY2015 FY2016 FY2017E FY2018E Total operating income 349 329 347 369 561 % chg 4.8 (5.9) 5.6 6.2 52.0 Total Expenditure 225 195 197 211 324 Operating Expenses 117 138 144 153 234 Purchases of Traded Goods 60 - - - - Personnel Expenses 19 22 25 28 44 Others Expenses 29 34 29 30 45 EBITDA 124 134 150 158 237 % chg 21.9 7.9 12.2 5.4 49.9 (% of Net Sales) 35.5 40.7 43.2 42.9 42.3 Depreciation& Amortisation 13 15 19 21 23 EBIT 111 119 131 137 214 % chg 21.3 6.8 10.2 5.0 55.9 (% of Net Sales) 31.8 36.1 37.7 37.2 38.2 Interest & other Charges 33 26 23 31 34 Other Income 4 2 23 15 14 (% of PBT) 4.7 2.3 17.7 12.4 7.0 Share in profit of Associates - - - - - Recurring PBT 82 94 131 121 193 % chg 28.4 15.3 38.6 (7.4) 59.5 Prior Period & Extra. Exp./(Inc.) - - - - - PBT (reported) 82 94 131 121 193 Tax 9 12 19 18 29 (% of PBT) 10.8 12.4 14.6 15.0 15.0 PAT (reported) 73 83 112 103 164 Extraordinary Items 17 (14) (17) - - ADJ. PAT 90 68 95 103 164 % chg 58.7 (24.0) 39.0 8.2 59.5 (% of Net Sales) 25.8 20.8 27.4 27.9 29.3 Basic EPS (`) 6.3 4.8 6.7 7.2 11.5 Fully Diluted EPS (`) 6.3 4.8 6.7 7.2 11.5 % chg 58.7 (24.0) 39.0 8.2 59.5 December 2, 2016 6

Consolidated Balance Sheet Y/E March (` cr) FY2014 FY2015 FY2016 FY2017E FY2018E SOURCES OF FUNDS Equity Share Capital 21 112 145 145 145 Reserves& Surplus 407 638 1,153 1,256 1,421 Shareholders Funds 428 750 1,298 1,401 1,565 Minority Interest - - - - - Total Loans 437 555 452 440 420 Deferred Tax Liability 28 33 33 33 33 Total Liabilities 893 1,338 1,783 1,874 2,018 APPLICATION OF FUNDS Gross Block 699 1,133 1,256 1,529 1,549 Less: Acc. Depreciation 43 59 79 100 123 Net Block 656 1,073 1,177 1,429 1,426 Capital Work-in-Progress 44 27 27 27 27 Investments 20 5 - - - Current Assets 198 253 603 435 592 Inventories - 2 2 3 5 Sundry Debtors 76 77 83 89 135 Cash 1 1 290 74 54 Loans & Advances 45 48 52 66 101 Other Assets 76 126 175 203 297 Current liabilities 25 22 25 19 28 Net Current Assets 172 231 577 416 564 Deferred Tax Asset 1 1 1 1 1 Mis. Exp. not written off - - - - - Total Assets 893 1,338 1,783 1,874 2,018 December 2, 2016 7

Consolidated Cashflow Statement Y/E March (` cr) FY2014 FY2015 FY2016 FY2017E FY2018E Profit before tax 99 80 131 121 193 Depreciation 13 15 19 21 23 Change in Working Capital (29) 7 (56) (56) (167) Interest / Dividend (Net) 33 26 23 31 34 Direct taxes paid (16) (22) (19) (18) (29) Others (17) 18 - - - Cash Flow from Operations 82 123 98 99 55 (Inc.)/ Dec. in Fixed Assets (93) (209) (123) (273) (20) (Inc.)/ Dec. in Investments - 15 5 - - Cash Flow from Investing (93) (194) (118) (273) (20) Issue of Equity 35-453 - - Inc./(Dec.) in loans 10 97 (103) (12) (20) Dividend Paid (Incl. Tax) - - - - - Interest / Dividend (Net) 1 (27) 413 (31) (34) Cash Flow from Financing 10 71 310 (43) (54) Inc./(Dec.) in Cash (1) 0 289 (217) (20) Opening Cash balances 2 1 1 290 74 Closing Cash balances 1 1 290 74 54 December 2, 2016 8

Key Ratios Y/E March FY2014 FY2015 FY2016 FY2017E FY2018E Valuation Ratio (x) P/E (on FDEPS) 27.7 36.5 26.2 24.2 15.2 P/CEPS 29.0 25.5 19.1 20.1 13.3 P/BV 5.8 3.3 1.9 1.8 1.6 Dividend yield (%) 0.0 0.0 0.0 0.0 0.0 EV/Sales 8.3 9.3 7.7 7.8 5.1 EV/EBITDA 23.5 22.8 17.7 18.1 12.1 EV / Total Assets 3.2 2.2 1.5 1.5 1.4 Per Share Data (`) EPS (Basic) 6.3 4.8 6.7 7.2 11.5 EPS (fully diluted) 6.3 4.8 6.7 7.2 11.5 Cash EPS 6.0 6.9 9.2 8.7 13.1 DPS 0.0 0.0 0.0 0.0 0.0 Book Value 30.0 52.6 91.0 98.3 109.8 Returns (%) ROCE 12.8 9.1 7.5 7.5 10.8 Angel ROIC (Pre-tax) 13.2 9.1 9.0 7.8 11.1 ROE 21.0 9.1 7.3 7.3 10.5 Turnover ratios (x) Asset Turnover (Gross Block) 0.5 0.3 0.3 0.2 0.4 Inventory / Sales (days) - 2 2 3 3 Receivables (days) 80 86 87 88 88 Payables (days) 7 7 5 4 4 Wc cycle (ex-cash) (days) 72 81 84 87 87 December 2, 2016 9

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Private Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Private Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Pvt. Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Pvt. Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Pvt. Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement Navkar Corporation 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period): Reduce (-5% to -15%) Sell (< -15) December 2, 2016 10